Further, stratification according to clinical data (menopausal status and vital status of the patients' and FIGO stage) and histopathological data (histological type and grade of the tumor, depth of myometrial invasion, and presence of lymphovascular invasion) revealed differences in STS, SULT1E1, and HSD17B14 expression (Table 3). The gene discussed is HSD17B14; the disease is neoplasm.